Anna Glaser

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF NEUROLOGY. 2024;271(6):3616-3624
Big Multiple Sclerosis Data network: an international registry research network
Glaser A; Butzkueven H; van der Walt A; Gray O; Spelman T; Zhu C; Trojano M; Iaffaldano P; Battaglia MA; Lucisano G; Vukusic S; Vukusic I; Casey R; Horakova D; Drahota J; Magyari M; Joensen H; Pontieri L; Elberling F; Klyve P; Mouresan EF; Forsberg L; Hillert J
Article: JAMA NETWORK OPEN. 2023;6(9):e2334675
Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context
He A; Manouchehrinia A; Glaser A; Ciccarelli O; Butzkueven H; Hillert J; Mckay KA
Article: MULTIPLE SCLEROSIS JOURNAL. 2023;29(9):1126-1135
Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis
He AH; Manouchehrinia A; Glaser A; Ciccarelli O; Butzkueven H; Hillert J; McKay KA
Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2023;69:104456
Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in Sweden
Teni FS; Machado A; Murley C; He A; Fink K; Gyllensten H; Glaser A; Alexanderson K; Hillert J; Friberg E
Article: MULTIPLE SCLEROSIS JOURNAL - EXPERIMENTAL, TRANSLATIONAL AND CLINICAL. 2023;9(1):20552173231153557
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers
Forsberg L; Spelman T; Klyve P; Manouchehrinia A; Ramanujam R; Mouresan E; Drahota J; Horakova D; Joensen H; Pontieri L; Magyari M; Ellenberger D; Stahmann A; Rodgers J; Witts J; Middleton R; Nicholas R; Bezlyak V; Adlard N; Hach T; Lines C; Vukusic S; Soilu-Hanninen M; van der Walt A; Butzkueven H; Iaffaldano P; Trojano M; Glaser A; Hillert J
Article: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 2023;16:17562864231198963
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe
Nicholas R; Rodgers J; Witts J; Lerede A; Friede T; Hillert J; Forsberg L; Glaser A; Manouchehrinia A; Ramanujam R; Spelman T; Klyve P; Drahota J; Horakova D; Joensen H; Pontieri L; Magyari M; Ellenberger D; Stahmann A; Butzkueven H; Van der Walt A; Bezlyak V; Lines C; Middleton R
Article: FRONTIERS IN NEUROLOGY. 2023;14:1274194
Predictors of treatment switching in the Big Multiple Sclerosis Data Network
Spelman T; Magyari M; Butzkueven H; van der Walt A; Vukusic S; Trojano M; Iaffaldano P; Horakova D; Drahota J; Pellegrini F; Hyde R; Duquette P; Lechner-Scott J; Sajedi SA; Lalive P; Shaygannejad V; Ozakbas S; Eichau S; Alroughani R; Terzi M; Girard M; Kalincik T; Grand'Maison F; Skibina O; Khoury SJ; Yamout B; Sa MJ; Gerlach O; Blanco Y; Karabudak R; Oreja-Guevara C; Altintas A; Hughes S; Mccombe P; Ampapa R; de Gans K; Mcguigan C; Soysal A; Prevost J; John N; Inshasi J; Stawiarz L; Manouchehrinia A; Forsberg L; Sellebjerg F; Glaser A; Pontieri L; Joensen H; Rasmussen PV; Sejbaek T; Poulsen MB; Christensen JR; Kant M; Stilund M; Mathiesen H; Hillert J
Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2022;9(7):962-976
Copy number variations across the blood-brain barrier in multiple sclerosis
Bedri SK; Evertsson B; Khademi M; Al Nimer F; Olsson T; Hillert J; Glaser A
Article: MULTIPLE SCLEROSIS JOURNAL. 2022;28(7):1051-1059
Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry
Spelman T; Forsberg L; McKay K; Glaser A; Hillert J
Article: MULTIPLE SCLEROSIS JOURNAL. 2022;28(2):237-246
A comparative study of teriflunomide and dimethyl fumarate within the Swedish MS Registry
Hillert J; Tsai JA; Nouhi M; Glaser A; Spelman T
Article: NEUROLOGY. 2021;97(19):e1870-e1885
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
Simpson-Yap S; De Brouwer E; Kalincik T; Rijke N; Hillert JA; Walton C; Edan G; Moreau Y; Spelman T; Geys L; Parciak T; Gautrais C; Lazovski N; Pirmani A; Ardeshirdavanai A; Forsberg L; Glaser A; McBurney R; Schmidt H; Bergmann AB; Braune S; Stahmann A; Middleton R; Salter A; Fox RJ; van der Walt A; Butzkueven H; Alroughani R; Ozakbas S; Rojas JI; van der Mei I; Nag N; Ivanov R; do Olival GS; Dias AE; Magyari M; Brum D; Mendes MF; Alonso RN; Nicholas RS; Bauer J; Chertcoff AS; Zabalza A; Arrambide G; Fidao A; Comi G; Peeters L
Article: MULTIPLE SCLEROSIS JOURNAL. 2019;25(8):1102-1112
Predicting risk of secondary progression in multiple sclerosis: A nomogram
Manouchehrinia A; Zhu F; Piani-Meier D; Lange M; Silva DG; Carruthers R; Glaser A; Kingwell E; Tremlett H; Hillert J
Article: MULTIPLE SCLEROSIS JOURNAL. 2019;25(1):104-112
Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical disability.
Kavaliunas A; Danylaite Karrenbauer V; Gyllensten H; Manouchehrinia A; Glaser A; Olsson T; Alexanderson K; Hillert J
Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2019;27:171-178
Multiple sclerosis registries in Europe - An updated mapping survey
Glaser A; Stahmann A; Meissner T; Flachenecker P; Horakova D; Zaratin P; Brichetto G; Pugliatti M; Rienhoff O; Vukusic S; de Giacomoni AC; Battaglia MA; Brola W; Butzkueven H; Casey R; Drulovic J; Eichstaedt K; Hellwig K; Iaffaldano P; Ioannidou E; Kuhle J; Lycke K; Magyari M; Malbasa T; Middleton R; Myhr KM; Notas K; Orologas A; Otero-Romero S; Pekmezovic T; Sastre-Garriga J; Seeldrayers P; Soilu-Hanninen M; Stawiarz L; Trojano M; Ziemssen T; Hillert J; Thalheim C
Article: PLOS ONE. 2019;14(5):e0217208
Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment
Bedri SK; Nilsson OB; Fink K; Manberg A; Hamsten C; Ayoglu B; Manouchehrinia A; Nilsson P; Olsson T; Hillert J; Gronlund H; Glaser A
Article: CLINICAL IMMUNOLOGY. 2018;187:15-25
Multiple sclerosis treatment effects on plasma cytokine receptor levels
Bedri SK; Fink K; Manouchehrinia A; Lundstrom W; Kockum I; Olsson T; Hillert J; Glaser A
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(14):1938-1946
Age Related Multiple Sclerosis Severity Score: Disability ranked by age
Manouchehrinia A; Westerlind H; Kingwell E; Zhu F; Carruthers R; Ramanujam R; Ban M; Glaser A; Sawcer S; Tremlett H; Hillert J
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(9):1233-1240
Importance of early treatment initiation in the clinical course of multiple sclerosis
Kavaliunas A; Manouchehrinia A; Stawiarz L; Ramanujam R; Agholme J; Hedstrom AK; Beiki O; Glaser A; Hillert J
Article: PLOS ONE. 2017;12(1):e0169460
Income in Multiple Sclerosis Patients with Different Disease Phenotypes
Kavaliunas A; Manouchehrinia A; Karrenbauer VD; Gyllensten H; Glaser A; Alexanderson K; Hillert J
Article: HUMAN MOLECULAR GENETICS. 2015;24(19):5644-5654
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis
Gu BJ; Field J; Dutertre S; Ou A; Kilpatrick TJ; Lechner-Scott J; Scott R; Lea R; Taylor BV; Stankovich J; Butzkueven H; Gresle M; Laws SM; Petrou S; Hoffjan S; Akkad DA; Graham CA; Hawkins S; Glaser A; Bedri SK; Hillert J; Matute C; Antiguedad A; Wiley JS
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2015;22(2):328-333
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.
Sundal C; Baker M; Karrenbauer V; Gustavsen M; Bedri S; Glaser A; Myhr K-M; Haugarvoll K; Zetterberg H; Harbo H; Kockum I; Hillert J; Wszolek Z; Rademakers R; Andersen O
Article: PLOS ONE. 2015;10(12):e0145435
Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis Patients
Kavaliunas A; Wiberg M; Tinghog P; Glaser A; Gyllensten H; Alexanderson K; Hillert J
Article: MULTIPLE SCLEROSIS JOURNAL. 2014;20(11):1523-1532
Multiple sclerosis registries in Europe - results of a systematic survey
Flachenecker P; Buckow K; Pugliatti M; Kes VB; Battaglia MA; Boyko A; Confavreux C; Ellenberger D; Eskic D; Ford D; Friede T; Fuge J; Glaser A; Hillert J; Holloway E; Ioannidou E; Kappos L; Kasilingam E; Koch-Henriksen N; Kuhle J; Lepore V; Middleton R; Myhr K-M; Orologas A; Otero S; Pitschnau-Michel D; Rienhoff O; Sastre-Garriga J; Schyns-Liharska T; Sutovic D; Thalheim C; Trojano M; Vlasov YV; Yaldizli O
Article: BMC NEUROLOGY. 2014;14:117
Co-morbidities increase the risk of disability pension among MS patients: a population-based nationwide cohort study
Tinghog P; Bjorkenstam C; Carstensen J; Jansson C; Glaser A; Hillert J; Alexanderson K
Article: MULTIPLE SCLEROSIS JOURNAL. 2013;19(14):1923-1930
High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study
Tinghog P; Hillert J; Kjeldgard L; Wiberg M; Glaser A; Alexanderson K
Article: JOURNAL OF NEUROIMMUNOLOGY. 2013;254(1-2):170-173
Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients
Karrenbauer VD; Prejs R; Masterman T; Hillert J; Glaser A; Imrell K
Article: ACTA NEUROLOGICA SCANDINAVICA, SUPPLEMENT. 2012;126(195):24-30
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS
Pugliatti M; Eskic D; Mikolcic T; Pitschnau-Michel D; Myhr K-M; Sastre-Garriga J; Otero S; Wieczynska L; Torje C; Holloway E; Rienhoff O; Friede T; Buckow K; Ellenberger D; Hillert J; Glaser A; Flachenecker P; Fuge J; Schyns-Liharska T; Kasilingam E; Moretti A; Thalheim C
Article: ALZHEIMER DISEASE AND ASSOCIATED DISORDERS. 2011;25(2):173-178
Novel progranulin mutation detected in 2 patients with FTLD.
Skoglund L; Matsui T; Freeman SH; Wallin A; Blom ES; Frosch MP; Growdon JH; Hyman BT; Lannfelt L; Ingelsson M; Glaser A
Article: NEUROSCIENCE LETTERS. 2010;469(2):265-267
CALHM1 P86L polymorphism does not alter amyloid-beta or tau in cerebrospinal fluid.
Giedraitis V; Glaser A; Sarajärvi T; Brundin R; Gunnarsson MD; Schjeide B-M; Tanzi RE; Helisalmi S; Pirttilä T; Kilander L; Lannfelt L; Soininen H; Bertram L; Ingelsson M; Hiltunen M
Article: BMC MEDICAL GENETICS. 2009;10:122
Further analysis of previously implicated linkage regions for Alzheimer's disease in affected relative pairs.
Blom ES; Giedraitis V; Arepalli S; Hamshere ML; Adighibe O; Goate A; Williams J; Lannfelt L; Hardy J; Vrièze FW-D; Glaser A
Article: ALZHEIMER DISEASE AND ASSOCIATED DISORDERS. 2009;23(3):298-300
Frontotemporal Dementia-amyotrophic Lateral Sclerosis Complex is Simulated by Neurodegeneration With Brain Iron Accumulation
Santillo AF; Skoglund L; Lindau M; Eeg-Olofsson KE; Tovi M; Engler H; Brundin R-M; Ingvast S; Lannfelt L; Glaser A; Kilander L
Article: NEUROGENETICS. 2009;10(1):27-34
Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation.
Skoglund L; Brundin R; Olofsson T; Kalimo H; Ingvast S; Blom ES; Giedraitis V; Ingelsson M; Lannfelt L; Basun H; Glaser A
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2009;28(5):471-475
No evidence of PGRN or MAPT gene dosage alterations in a collection of patients with frontotemporal lobar degeneration.
Skoglund L; Ingvast S; Matsui T; Freeman SH; Frosch MP; Brundin R; Giedraitis V; Growdon JH; Hyman BT; Lannfelt L; Ingelsson M; Glaser A
Article: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2009;27(1):59-68
Genetic analysis of Alzheimer's disease in the Uppsala Longitudinal Study of Adult Men.
Giedraitis V; Kilander L; Degerman-Gunnarsson M; Sundelöf J; Axelsson T; Syvänen A-C; Lannfelt L; Glaser A
Article: AMERICAN JOURNAL OF MEDICAL GENETICS, PART B: NEUROPSYCHIATRIC GENETICS. 2008;147B(6):778-783
Does APOE explain the linkage of Alzheimer's disease to chromosome 19q13?
Blom ES; Holmans P; Arepalli S; Adighibe O; Hamshere ML; Gatz M; Pedersen NL; Bergem ALM; Owen MJ; Hollingworth P; Goate A; Williams J; Lannfelt L; Hardy J; Vrieze FW-D; Glaser A
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2008;16(2):171-175
Low prevalence of APP duplications in Swedish and Finnish patients with early-onset Alzheimer's disease.
Blom ES; Viswanathan J; Kilander L; Helisalmi S; Soininen H; Lannfelt L; Ingelsson M; Glaser A; Hiltunen M
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2008;15(2):156-161
The tau S305S mutation causes frontotemporal dementia with parkinsonism
Skoglund L; Viitanen M; Kalimo H; Lannfelt L; Joenhagen ME; Ingelsson M; Glaser A; Herva R
Article: NEUROGENETICS. 2007;8(3):179-188
Association study of cholesterol-related genes in Alzheimer's disease.
Wollmer MA; Sleegers K; Ingelsson M; Zekanowski C; Brouwers N; Maruszak A; Brunner F; Huynh K-D; Kilander L; Brundin R-M; Hedlund M; Giedraitis V; Glaser A; Engelborghs S; De Deyn PP; Kapaki E; Tsolaki M; Daniilidou M; Molyva D; Paraskevas GP; Thal DR; Barcikowska M; Kuznicki J; Lannfelt L; Van Broeckhoven C; Nitsch RM; Hock C; Papassotiropoulos A
Article: JOURNAL OF MEDICAL GENETICS. 2006;43(12):931-935
New Alzheimer's disease locus on chromosome 8.
Giedraitis V; Hedlund M; Skoglund L; Blom E; Ingvast S; Brundin R; Lannfelt L; Glaser A
Article: NEUROSCIENCE LETTERS. 2004;363(2):99-101
No evidence for tau duplications in frontal temporal dementia families showing genetic linkage to the tau locus in which tau mutations have not been found.
Johnson J; Ostojic J; Lannfelt L; Glaser A; Basun H; Rogaeva E; Kawarai T; Bruni A; St George Hyslop PH; Goate A; Pastor P; Chakraverty S; Norton J; Morris JC; Hardy J; Singleton A
Article: NEURODEGENERATIVE DISEASES. 2004;1(4-5):218-224
Clinical and molecular aspects of frontotemporal dementia.
Froelich-Fabre S; Skoglund L; Ostojic J; Kilander L; Lindau M; Glaser A; Basun H; Lannfelt L
Article: JOURNAL OF IMMUNOLOGY. 2003;170(2):1062-1069
New loci regulating rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis
Becanovic K; Wallstrom E; Kornek B; Glaser A; Broman KW; Dahlman I; Ofsson P; Holmdahl R; Luthman H; Lassmann H; Olsson T
Article: MAMMALIAN GENOME. 1999;10(11):1102-1105
A rat genetic linkage map including 67 new microsatellite markers
Fakhrai-Rad H; Jiao H; Li LS; Glaser A; Koike G; Jacob HJ; Luthman H; Galli J
Article: JOURNAL OF IMMUNOLOGY. 1999;162(5):2581-2588
Genome-wide linkage analysis of chronic relapsing experimental autoimmune encephalomyelitis in the rat identifies a major susceptibility locus on chromosome 9
Dahlman I; Jacobsson L; Glaser A; Lorentzen JC; Andersson M; Luthman H; Olsson T
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1998;95(11):6383-6387
Identification of rat susceptibility loci for adjuvant-oil-induced arthritis
Lorentzen JC; Glaser A; Jacobsson L; Galli J; Fakhrai-Rad H; Klareskog L; Luthman H
Article: GENOMICS. 1996;38(1):96-99
Genetic mapping and chromosome localization of the rat mitochondrial glycerol-3-phosphate dehydrogenase gene, a candidate for non-insulin-dependent diabetes mellitus
Koike G; VanVooren P; Shiozawa M; Galli J; Li LS; Glaser A; Balasubramanyam A; Brown LJ; Luthman H; Szpirer C; MacDonald MJ; Jacob HJ
Article: NATURE GENETICS. 1996;12(1):31-37
Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat
Galli J; Li LS; Glaser A; Ostenson CG; Jiao H; FakhraiRad H; Jacob HJ; Lander ES; Luthman H
Visa fler

Alla övriga publikationer

Published conference paper: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 2015;822:19-24
The Influence of Immunomodulatory Treatment on the Clinical Course of Multiple Sclerosis
Kavaliunas A; Stawiarz L; Hedbom J; Glaser A; Hillert J
Meeting abstract: NEUROBIOLOGY OF AGING. 2004;25:S522
Genetic analysis of stroke and dementia in two Swedish families
Ingvast S; Blom E; Hedlund M; Giedraitis V; Glaser A; Lannfelt L
Meeting abstract: NEUROBIOLOGY OF AGING. 2004;25:S518
Gene mapping in a family with multiple affected cases of frontotemporal dementia
Skoglund L; Brundin RM; Lindau M; Kilander L; Glaser A; Lannfelt L
Meeting abstract: NEUROBIOLOGY OF AGING. 2004;25:S498
Disease susceptibility locus for familial AD on chromosome 8
Giedraitis V; Hedlund M; Skoglund L; Blom E; Ingvast S; Lannfelt L; Glaser A
Meeting abstract: NEUROBIOLOGY OF AGING. 2004;25:S494
Is APOE exclusively responsible for the AD linkage peak on chromosome 19?
Blom E; Holmans O; Arepalli S; Adighibe O; Hardy J; Lannfelt L; Glaser A; Wavrant-De Vrièze F

Anställningar

Senior Forskningsspecialist, Klinisk neurovetenskap, Karolinska Institutet, 2021-

Examina och utbildning

Docent, Molekylär genetik, Karolinska Institutet, 2011

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI